Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Share-based Compensation (2021 - 2025)

Historic Share-based Compensation for Core Scientific (CORZ) over the last 5 years, with Q3 2025 value amounting to $29.9 million.

  • Core Scientific's Share-based Compensation rose 4591.43% to $29.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $94.3 million, marking a year-over-year increase of 10747.88%. This contributed to the annual value of $51.9 million for FY2024, which is 1183.18% down from last year.
  • Latest data reveals that Core Scientific reported Share-based Compensation of $29.9 million as of Q3 2025, which was up 4591.43% from $24.2 million recorded in Q2 2025.
  • Core Scientific's Share-based Compensation's 5-year high stood at $111.0 million during Q2 2022, with a 5-year trough of -$1.1 million in Q1 2024.
  • Its 5-year average for Share-based Compensation is $21.2 million, with a median of $16.3 million in 2022.
  • In the last 5 years, Core Scientific's Share-based Compensation surged by 509653.56% in 2022 and then tumbled by 10863.68% in 2024.
  • Quarter analysis of 5 years shows Core Scientific's Share-based Compensation stood at $7.9 million in 2021, then skyrocketed by 106.26% to $16.3 million in 2022, then increased by 6.93% to $17.5 million in 2023, then soared by 37.13% to $24.0 million in 2024, then increased by 24.95% to $29.9 million in 2025.
  • Its Share-based Compensation was $29.9 million in Q3 2025, compared to $24.2 million in Q2 2025 and $16.2 million in Q1 2025.